Gee-Hong Kuo

Title: Innovations of Gee-Hong Kuo

Introduction

Gee-Hong Kuo is a notable inventor based in East Greenbush, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 2 patents to his name, Kuo's work focuses on innovative chemical compositions that have potential therapeutic applications.

Latest Patents

Kuo's latest patents include "Imidazopyridines, compositions and use - 1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones having an aryl or heteroaryl group in the 6-position, useful as phosphodiesterase inhibitors." This invention involves the preparation of compounds by reacting a 2-amino-5-(aryl or heteroaryl)pyridine-3-carboxylic acid with diphenylphosphoryl azide. The compounds are characterized by specific structural formulas where R1 and R3 can be hydrogen or lower-alkyl, R5 can be lower-alkyl or fluorinated lower-alkyl, and Ar can be 4- or 3-pyridinyl, or phenyl or substituted phenyl. Another patent, "Imidazopyridines, their preparation and use," also focuses on similar compounds and their applications as phosphodiesterase inhibitors.

Career Highlights

Gee-Hong Kuo is currently associated with Sterling Drug Inc., where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug development, particularly in creating compounds that may lead to new therapeutic options.

Collaborations

Kuo has collaborated with notable colleagues such as Edward R Bacon and Baldev Singh, enhancing the research and development efforts within his field.

Conclusion

Gee-Hong Kuo's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for new therapeutic possibilities in medicine.